These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7396470)

  • 41. What is the Intraarticular Concentration of Tobramycin Using Low-dose Tobramycin Bone Cement in TKA: An In Vivo Analysis?
    Vrabec G; Stevenson W; Elguizaoui S; Kirsch M; Pinkowski J
    Clin Orthop Relat Res; 2016 Nov; 474(11):2441-2447. PubMed ID: 27488378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
    Woo FL; Johnson AP; Insler MS; George WJ; LaCorte WS
    Arch Ophthalmol; 1985 Feb; 103(2):216-8. PubMed ID: 3977692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dosage adjustment and clinical outcomes of long-term use of high-dose tobramycin in adult cystic fibrosis patients.
    Li SC; Bowes G; Ioannides-Demos LL; Spicer WJ; Hooper RE; Spelman DW; Tong N; McLean AJ
    J Antimicrob Chemother; 1991 Oct; 28(4):561-8. PubMed ID: 1761450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of twelve burn wound infections and eight other serious infections with cefazolin and tobramycin: in vitro and in vivo evaluation.
    Franson TR; Edwards LD; Collins RF; Root TE
    Chemotherapy; 1980; 26(5):384-96. PubMed ID: 7389430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
    Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.
    Dopfer R; Brand P; Müllinger B; Hunger T; Häussermann S; Meyer T; Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):141-54. PubMed ID: 18204125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tobramycin dosing in mechanically ventilated patients. Inaccuracy of a 'rule of thumb'.
    Martin C; Mallet MN; Saux P; Bruguerolle B; Herat V; Gouin F
    J Antimicrob Chemother; 1988 Oct; 22(4):505-11. PubMed ID: 3204077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic efficacy of tobramycin--a clinical and laboratory evaluation.
    Uwaydah M; Bibi S; Salman S
    J Antimicrob Chemother; 1975 Dec; 1(4):429-37. PubMed ID: 1107297
    [No Abstract]   [Full Text] [Related]  

  • 50. Timing of inhaled tobramycin affects assessment of intravenous tobramycin pharmacokinetic monitoring.
    Stenbit AE; Bullington WM; Heh JL; Flume PA
    J Cyst Fibros; 2013 Jul; 12(4):403-6. PubMed ID: 23266092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical evaluations of tobramycin in treatment of chronic complicated urinary tract infections by intravenous drip infusion administration (author's transl)].
    Suzuki K
    Jpn J Antibiot; 1982 Feb; 35(2):409-20. PubMed ID: 7087177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria.
    Meyers BR
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):38-40. PubMed ID: 600202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R; Rachlis A; Tuffnell PG; Duncan I; Moran L; Pinfold P; DeBoer G
    Arch Intern Med; 1984 May; 144(5):1005-10. PubMed ID: 6712393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacology of tobramycin in infants.
    Bratlid D; Fuglesang JE
    Scand J Infect Dis; 1979; 11(1):73-6. PubMed ID: 419372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tobramycin nephrotoxicity. A prospective clinical study.
    Coca A; Blade J; Martinez A; Segura F; Soriano E; Ribas-Mundo M
    Postgrad Med J; 1979 Nov; 55(649):791-6. PubMed ID: 523366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimisation of aminoglycoside toxicity in patients with cystic fibrosis.
    Wood PJ; Ioannides-Demos LL; Li SC; Williams TJ; Hickey B; Spicer WJ; Hooper RE; McLean AJ
    Thorax; 1996 Apr; 51(4):369-73. PubMed ID: 8733487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.